Mental disorders in antiphospholipid syndrome patients: association with clinical and immunological manifestations of the disease

QR Code

Mental disorders in antiphospholipid syndrome patients: association with clinical and immunological manifestations of the disease

The aim of this work is to clarify the association between the clinical and psychopathological features of mental disorders (MD) and the clinical and immunological features of antiphospholipid syndrome (APS).Material and methods. The study included 107 patients (34 (31.8%) men and 73 (68.2%) women)...

Full description

Saved in:

Bibliographic Details
Main Authors:	А. В. Borisova, Т. А. Lisitsyna, D. Yu. Veltishchev, Т. М. Reshetnyak, О. F. Seravina, О. В. Kovalevskaya, F. А. Cheldieva, А. А. Abramkin, А. Е. Zeltyn, Е. L. Nasonov
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2024-04-01
Series:	Научно-практическая ревматология
Subjects:	antiphospholipid syndrome activity gapss mental disorders depression cognitive impairment
Online Access:	https://rsp.mediar-press.net/rsp/article/view/3547
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Assessment of the activity and organ damage in antiphospholipid syndrome
by: F. A. Cheldieva, et al.
Published: (2021-08-01)

Global Antiphospholipid Syndrome Score (GAPSS) in patients with primary antiphospholipid syndrome
by: F. A. Cheldieva, et al.
Published: (2023-02-01)

Risk Factors for Recurrent Thrombosis in Patients with Antiphospholipid Syndrome—A Single-Centre Cohort Study
by: Natali Karandyszowska, et al.
Published: (2025-01-01)

Anxiety-depressive spectrum disorders in patients with obstetric antiphospholipid syndrome
by: A. B. Borisova, et al.
Published: (2024-12-01)

ANTIPHOSPHOLIPID SYNDROME: DIAGNOSIS AND CLINICAL MANIFESTATIONS (A LECTURE)
by: Tat’yana M Reshetnyak
Published: (2014-03-01)

Clinical and immunological features of primary and secondary antiphospholipid syndrome
by: T M Reshetnvak, et al.
Published: (2004-08-01)

Pregnancy and its outcome in antiphospholipid syndrome after acute cerebral circulatory failure (clinical case study)
by: T. M. Reshetnyak, et al.
Published: (2024-06-01)

Global antiphospholipid syndrome score (GAPSS) in patients with systemic lupus erythematosus
by: F. A. Cheldieva, et al.
Published: (2022-11-01)

Thromboembolic complications in antiphospholipid syndrome and ankylosing spondylitis (two clinical cases)
by: K. S. Nurbaeva, et al.
Published: (2021-02-01)

THE IX EUROPEAN FORUM ON ANTIPHOSPHOLIPID ANTIBODIES. A BRIEF REVIEW
by: Nataliya V Seredavkina, et al.
Published: (2014-03-01)

Antibodies to domain I β2 -glycoprotein 1 in patients with antiphospholipid syndrome and systemic lupus erythematosus
by: F. A. Cheldieva, et al.
Published: (2022-07-01)

Direct-acting oral anticoagulants in antiphospholipid syndrome
by: T. M. Reshetnyak, et al.
Published: (2021-01-01)

Extra criterial antiphospholipid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus (preliminary data)
by: F. A. Cheldieva, et al.
Published: (2021-10-01)

RECURRENT FETAL LOSS IN THE PRIMARY ANTIPHOSPHOLIPID SYNDROME (CASE REPORT)
by: Z S Alekberova, et al.
Published: (2000-02-01)

History of antiphospholipid syndrome
by: М. Р. Drozhzhina, et al.
Published: (2024-03-01)

Thrombotic antiphospholipid syndrome: Recurrent thromboses
by: Tatiana M. Reshetnyak, et al.
Published: (2024-09-01)

Damage Burden in Polish Patients with Antiphospholipid Syndrome Measured Using Damage Index for Antiphospholipid Syndrome (DIAPS)
by: Ewa Haladyj, et al.
Published: (2025-07-01)

PREVENTION OF THROMBOSES IN ANTIPHOSPHOLIPID SYNDROME
by: Lyubov Valeryevna Kondratyeva, et al.
Published: (2009-09-01)

Assessment of antiphospholipid antibodies using enzyme-linked immunosorbent assay and chemiluminescent method
by: T. M. Reshetnyak, et al.
Published: (2025-04-01)

ANTIPHOSPHOLIPID ANTIBODIES, THEIR PATHOGENETIC AND DIAGNOSTIC ISSUES OBSTETRIC PRACTICE
by: V. O. Bitsadze, et al.
Published: (2016-06-01)

Clinical significance of the determination of antibodies to the NR2 subunit of glutamate N-methyl-D-aspartate receptors (aNMDAR) in patients with systemic lupus erythematosus and antiphospholipid syndrome
by: T. A. Lisitsyna, et al.
Published: (2025-05-01)

Catastrophic antiphospholipid COVID-19 syndrome
by: Yu. S. Polushin, et al.
Published: (2021-03-01)

NEW ORAL ANTICOAGULANTS IN THE THERAPY OF ANTIPHOSPHOLIPID SYNDROME
by: M. A. Satybaldyeva, et al.
Published: (2016-07-01)

Efficacy and safety of long-term use of low molecular weight heparins in patients with systemic lupus erythematosus and antiphospholipid syndrome
by: N. V. Seredavkina, et al.
Published: (2023-10-01)

Difficulties in management of patients with systemic lupus erythematosus and antiphospholipid syndrome in combination with melanoma and infiltrative tuberculosis (clinical observations)
by: A. A. Shumilova, et al.
Published: (2021-08-01)

Cognitive impairments in patients with rheumatoid arthritis and comorbid anxiety and depressive disorders: Outcomes of the five-years prospective study
by: A. A. Abramkin, et al.
Published: (2024-11-01)

КОГНИТИВНЫЕ НАРУШЕНИЯ ПРИ САХАРНОМ ДИАБЕТЕ У ЛИЦ ПОЖИЛОГО ВОЗРАСТА
by: А. А. Фирсов, et al.
Published: (2014-08-01)

Gestation in patients with a combination of antiphospholipid and torch syndromes
by: E. N. Kravchenko, et al.
Published: (2021-07-01)

ANTIPHOSPHOLIPID SYNDROME AND SYSTEMIC LUPUS ERYTHEMATOSUS: WHAT DISEASE IS A CAUSE OF ORGAN DAMAGES?
by: F. A. Cheldieva, et al.
Published: (2020-04-01)

On the pathogenesis of thromboses in antiphospholipid syndrome
by: T. A. Sukontseva, et al.
Published: (2018-11-01)

STUDIES DEVOTED TO ANTIPHOSPHOLIPID SYNDROME AT THE V.A. NASONOVA RESEARCH INSTITUTE OF RHEUMATOLOGY: MAIN ACHIEVEMENTS (ON THE OCCASION OF THE 40th ANNIVERSARY OF THE DISSERTATION BOARD)
by: T. M. Reshetnyak
Published: (2017-01-01)

EFFECTS OF SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS, BIOLOGICAL AGENTS, AND PSYCHOPHARMACOTHERAPY ON THE MENTAL DISORDERS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: A. A. Abramkin, et al.
Published: (2017-09-01)

A clinical case report: stroke in a young patient with systemic lupus erythematosus on the background of secondary antiphospholipid syndrome
by: S.I. Shkrobot, et al.
Published: (2022-12-01)

USE OF INTRAVENOUS IMMUNOGLOBULIN WITHIN THE IVF/ICSI PROTOCOL IN WOMEN WITH INFERTILITY AND ANTIPHOSPHOLIPID ANTIBODIES
by: M. I. Krivonos, et al.
Published: (2017-12-01)

Cytokines and neopterin in antiphospholipid syndrome
by: E N Alexandrova, et al.
Published: (2009-04-01)

КОРРЕКЦИЯ УГЛЕВОДНОГО ОБМЕНА У БОЛЬНЫХ С МЕТАБОЛИЧЕСКИМ СИНДРОМОМ ПО ДАНЫМ СУТОЧНОГО МОНИТОРИРОВАНИЯ ГЛИКЕМИИ
by: А. М. Шилов, et al.
Published: (2012-08-01)

ANTIPHOSPHOLIPID SYNDROME AND EARLY REPRODUCTIVE FAILURE
by: M. I. Krivonos, et al.
Published: (2017-03-01)

CIRCULATION OF ANTIPHOSPHOLIPID ANTIBODIES AND IVF FAILURES
by: N. S. Stuleva, et al.
Published: (2016-06-01)

Use of plasmapheresis and intravenous immunoglobulins in pregnant women with antiphospholipid syndrome
by: E. S. Orlova, et al.
Published: (2025-01-01)

THE ROLE OF INFLAMMATION FOR THE WORSE OUTCOMES IN PATIENTS WITH ST ELEVATION MYOCARDIAL INFARCTION UNDERWENT TRANSCUTANEOUS CORONARY INTERVENTION, COMORBID WITH IMPAIRED GLUCOSE TOLERANCE
by: Ю. А. Беленькова, et al.
Published: (2014-08-01)